NCT01197560 2019-11-25
Study of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)
Celgene
Phase 2/3 Completed
Celgene
Asan Medical Center
H. Lee Moffitt Cancer Center and Research Institute
Sanofi